These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2715068)

  • 1. Chlorophenoxy acetic acid derivatives as hemoglobin modifiers and tumor radiosensitizers.
    Hirst DG; Wood PJ
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1183-6. PubMed ID: 2715068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered radiosensitivity in a mouse carcinoma after administration of clofibrate and bezafibrate.
    Hirst DG; Wood PJ
    Radiother Oncol; 1989 May; 15(1):55-61. PubMed ID: 2748943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour radiosensitization by clofibrate and its analogs: possible mechanisms.
    Hirst DG
    Adv Exp Med Biol; 1990; 277():917-25. PubMed ID: 2151413
    [No Abstract]   [Full Text] [Related]  

  • 4. The modification of hemoglobin affinity for oxygen and tumor radiosensitivity by antilipidemic drugs.
    Hirst DG; Wood PJ; Schwartz HC
    Radiat Res; 1987 Oct; 112(1):164-72. PubMed ID: 3477829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulations in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy.
    Siemann DW; Alliet KL; Macler LM
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1169-72. PubMed ID: 2715065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinnarizine and flunarizine as radiation sensitisers in two murine tumours.
    Wood PJ; Hirst DG
    Br J Cancer; 1988 Dec; 58(6):742-5. PubMed ID: 3224079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
    Kasai S; Nagasawa H; Kuwasaka H; Oshodani T; Nishioka A; Ogawa Y; Yoshida S; Inayama S; Inomata T; Hori H
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):799-802. PubMed ID: 9845099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain.
    Kagiya VT; Sugita T; Nishimoto S; Masuoka M; Zhou L; Abe M; Shibamoto Y; Sasai K
    Int J Radiat Oncol Biol Phys; 1992; 22(3):597-600. PubMed ID: 1735698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
    Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
    Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ; Menke D; Brown JM
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists as radiation modifiers: site specificity in relation to tumor response.
    Wood PJ; Hirst DG
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1141-4. PubMed ID: 2715060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunopotentiation effects of the bifunctional radiosensitizer KIN-806 in comparison with its analogs KIN-804 and KIN-844.
    Inomata T; Ogawa Y; Nishioka A; Hamada N; Ito S; Kariya S; Yoshida S; Nagasawa H; Hori H; Inayama S
    Oncol Rep; 1999; 6(6):1209-12. PubMed ID: 10523682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
    Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of severe tumor hypoxia by modifiers of the oxygen affinity of hemoglobin.
    Adams GE; Stratford IJ; Nethersell AB; White RD
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1179-82. PubMed ID: 2715067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
    Sun JR; Brown JM
    Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.
    Khandelwal SR; Kavanagh BD; Lin PS; Truong QT; Lu J; Abraham DJ; Schmidt-Ullrich RK
    Br J Cancer; 1999 Feb; 79(5-6):814-20. PubMed ID: 10070874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ tumour radiosensitization induced by clofibrate administration: single dose and fractionated studies.
    Calais G; Hirst DG
    Radiother Oncol; 1991 Oct; 22(2):99-103. PubMed ID: 1957008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
    Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle dose rate irradiation in combination with carbogen inhalation selectively and more markedly increases the responses of SCCVII tumors.
    Ono K; Masunaga S; Akuta K; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):81-5. PubMed ID: 8175449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.